NASDAQ
IXHL
Last Price
US $3.15
KEY FIGURES
MKT CAP
$37.7M
EPS
TTM$-3.61
EPS Growth (1Y)
-95.93%
PEG
TTMN/M
P/E
TTMN/M
P/S
TTM-
YIELD
—
Valuation
Financial
Performance
Cash flow to debt coverage
Incannex Healthcare Limited cash flow to debt ratio of -13.40K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Incannex Healthcare Limited's free cash flow has decreased 2.84% from $-12.52M last year to $-12.88M, signaling decreasing performance
Debt-to-equity ratio
Incannex Healthcare Limited's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Incannex Healthcare Limited's debt has decreased relative to shareholder equity from 0.02 last year to 0.00 today, signaling strengthened financials
Net debt to EBITDA
Incannex Healthcare Limited has a net cash position, so leverage is healthy.
Interest coverage
Incannex Healthcare Limited earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
Incannex Healthcare Limited's profit margin was -54.52K% last year and is -63.19K% this year, signaling decreasing performance
Current ratio
Incannex Healthcare Limited's short-term assets of $72.83M exceed its short-term liabilities of $1.49M
Return on assets
Incannex Healthcare Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Incannex Healthcare Limited's return on equity of -59.80%, is lower than 15.00%, indicating bad performance
Earnings quality
Incannex Healthcare Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Incannex Healthcare Limited has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Incannex Healthcare Limited has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Incannex Healthcare Limited has negative free cash flow, indicating cash burn
Earnings growth
Incannex Healthcare Limited's yearly earnings has increased 58.83% since last year from $-46.88M to $-19.30M, signaling increasing performance
Revenue growth
Incannex Healthcare Limited's yearly revenue has decreased 100.00% since last year from $86.00K to $0.00, signaling decreasing performance
Return on invested capital
ROIC -36.03% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Incannex Healthcare Limited has insufficient revenue history to calculate 3-year revenue CAGR.
Revenue consistency
Incannex Healthcare Limited had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance
Return on equity consistency
Incannex Healthcare Limited has insufficient public price history to evaluate ROE consistency.
Base Cash Flow Valuation (DCF)
Incannex Healthcare Limited has insufficient data to evaluate this check.
Earnings yield (TTM)
Incannex Healthcare Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Base EBITDA Valuation
Incannex Healthcare Limited is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model
EV/EBITDA (FY)
Incannex Healthcare Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Incannex Healthcare Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Incannex Healthcare Limited has a price-to-book ratio of 0.57x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Incannex Healthcare Limited has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-381.09%
Return on equity
ROIC: -343.56%
Valuation History
-
Price to Earnings
EV/EBITDA: -
Cash flow
Profit margin
GROWTH (5Y CAGR)
Revenue
-
EBITDA
-13.20%
Cash flow
-11.72%
Base Cash Flow Valuation (DCF)
Fair Value
Market $3.15
—
Default assumptions
Base EBITDA Valuation
Fair Value
Market $3.15
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.